18:02 EDT PacBio (PACB) sees FY26 revenue $165M-$175M, consensus $174.42M
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PACB:
- Pacific Biosciences (PACB) Q1 Earnings Cheat Sheet
- PacBio, Lucid Genomics announces collaboration to advance tertiary analysis
- PacBio price target lowered to $1 from $1.50 at Barclays
- Gitlab, Altimmune, Cheniere, Pacific Biosciences, Hercules Shock Wall Street
- Positioning PacBio for Scalable Growth: SPRQ-Nx, Reusable SMRT Cells, and the Trillion Gene Atlas as Key 2026–2027 Catalysts